bioAffinity Technologies

BIAFNasdaq United States Health Care Biotechnology: Commercial Physical & Biological Resarch

Market cap

$9.263 M

$7.94 -7.19%

Close of 23 Sept 2026

Revenue

$6.16M

#3252 by revenue

Earnings

-$14.9M

Loss-making

Shares outstanding

8,101,725

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

bioAffinity Technologies lists more than one class of stock. Company figures above cover all classes combined.

BIAFW

Biotechnology: Commercial Physical & Biological Resarch, ranked by market cap

All 12 →

#8Nrc HealthNRC$477.1M
#9MaxcyteMXCT$122.8M
#10OneMedNetONMD$38.8M
#11bioAffinity TechnologiesBIAF$9.26M
#12iSpecimenISPC$3.05M

What if bioAffinity Technologies were worth as much as…

Open the what-if tool →

Gold $29.8T

$25,583,993

Per share 3,222,165× higher

Bitcoin $1.69T

$1,452,155

Per share 182,891× higher

Nvidia $5.43T

$4,658,558

Per share 586,720× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for bioAffinity Technologies are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.